Overview

REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts

Status:
Not yet recruiting

Trial end date:
2026-09-15

Target enrollment:

Participant gender:

Summary

The main objective is to evaluate the efficacy of IV administration of the P2Y12 inhibitor (cangrelor) in addition to mecanich thrombectomy and WMD versus mecanich thrombectomy and WMD alone on the functional prognosis at 3 months, in patients with acute ischemic stroke eligible for mecanich thrombectomy on the basis of infusion imaging between 0 and 24 hours after the onset of symptoms.

Phase:

Phase 3

Details

Lead Sponsor:

Fondation Ophtalmologique Adolphe de Rothschild

Treatments:

Cangrelor